How aluminum adjuvants could promote and enhance non-target IgE synthesis in a genetically-vulnerable sub-population

Journal of Immunotoxicology

Volumn 10, Issue 2, 2013, Pages 210-222

  Terhune, Todd D ^a   Deth, Richard C ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Allergy; IL 12; IL 18; Inflammasome; NLRP3; TH1 TH2

Indexed keywords

ALUMINUM; ALUMINUM POTASSIUM SULFATE; CD23 ANTIGEN; CRYOPYRIN; DIPHTHERIA TETANUS VACCINE; GLUTATHIONE DISULFIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; IMMUNOLOGICAL ADJUVANT; INFLAMMASOME; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; KEYHOLE LIMPET HEMOCYANIN; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; PROSTAGLANDIN E2; THIOREDOXIN; THIOREDOXIN INTERACTING PROTEIN; THIOREDOXIN REDUCTASE; VACCINE;

ALLERGIC DISEASE; ATOPIC DERMATITIS; ATOPY; B LYMPHOCYTE; CYTOKINE RELEASE; DENDRITIC CELL; DRUG SAFETY; FAMILY HISTORY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; MACROPHAGE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ALUMINUM; ANIMALS; ANTIBODY FORMATION; CYTOKINES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOGLOBULIN E; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; POPULATION GROUPS; VACCINATION;

EID: 84877698169     PISSN: 1547691X     EISSN: None     Source Type: Journal    
DOI: 10.3109/1547691X.2012.708366     Document Type: Review

References (159)

1. Aaby, P., Shaheen, O. S., Heyes, B. C., Goudiaby, A., Hall, A. J., Shiell, A W., Jensen, H., and Marchant, A. 2000. Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin. Exp. Allergy 30:644-650. (Pubitemid 30305626)
2. Allakhverdi, Z., Smith, D. E., Comeau, M. R., and Delespesse, G. 2007. Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J. Immunol. 179:2051-2054.
3. Allen, I., Jania, C., Wilson, J., Tekeppe, E., Hua, X., Brickey, W., Kwan, M., Koller, B., Tilley, S., and Ting, J. 2012. Analysis of NLRP3 in the development of allergic airway disease in mice. J. Immunol. 188:2884-2893.
4. Alm, S. J., Swartz, J., Lilja, G., Scheynius, A., and Pershagen, G. 1999. Atopy in children of families with an anthroposophic lifestyle. Lancet 353:1485-1488. (Pubitemid 29204367)
5. Anderson, R. H., Poloniecki, D. J., Strachan, P. D., Beasley, R., Bjkst, B., and Asher, M. I. (The ISAAC Phase 1 Study Group). 2001. Immunization and symptoms of atopic disease in children: Results from the International Study of Asthma and Allergies. Am. J. Public Health 91:1126-1129. (Pubitemid 32574841)
6. Annus, T., Montgomery, M. S., Riikjarv, A. M., and Bjkst, B. 2004. Atopic disorders among Estonian schoolchildren in relation to tuberculin reactivity and the age at BCG vaccination. Allergy 59:1068-1073. (Pubitemid 39279104)
7. Aral, M., Arican, O., Gul, M., Sasmaz, S., Kocturk, S. A., Kastal, U., and Ekerbicer, H. C. 2006. The relationship between serum levels of total IgE, IL-18, IL-12, and IFNγ and disease severity in children with atopic dermatitis. Med. Inflamm. 4:73098.
8. Arkwright, P. D., Patel, L., Moran, M., Haeney, R., Ewing, C. I., and David, T. J. 2000. Atopic eczema is associated with delayed maturation of the antibody response to Pneumococcal vaccine. Clin. Exp. Immunol. 122:16-19.
9. Bager, P., Rostgaard, K., Nielsen, M. N., Melbye, M., and Westergaard, T. 2003. Age at bacille Calmette-Guerin vaccination and risk of allergy and asthma. Clin. Exp. Allergy 33:1512-1517. (Pubitemid 37421628)
10. Barrett, D. J., and Ayoub, E. M. 1986. IgG2 subclass restriction of antibody to pneumococcal polysaccharides. Clin. Exp. Immunol. 63:127-134. (Pubitemid 16196411)
11. Baynam, G., Khoo, S. K., Rowe, J., Zhang, G. Z., Laing, I., Hayden, C., Kusel, M., DeKlerk, N., Sly, P., Goldblatt, J., Holt, P., and Lesouef, P. 2007. Parental smoking impairs vaccine responses in children with atopic genotypes. J. Allergy Clin. Immunol. 119:366-374. (Pubitemid 46204792)
12. Baynam, G., Zhang, G., Khoo, S. K., Sly, P., Holt, P., Goldblatt, J., and Le Sou, P N. 2008. Gender-specific effects of cytokine gene polymorphisms on childhood vaccine responses. Vaccine 26:3574-3579.
13. Beck, L., and Spiegelberg, H. L. 1989. The polyclonal and antigenspecific IgE and IgG subclass response of mice injected with ovalbumin in alum or Complete Freund's Adjuvant. Cell Immunol. 123:1-8. (Pubitemid 19242675)
14. Bendelac, A., Rivera, M. N., Park, S. H., and Roak, J. H. 1997. Mouse CD1-specific NK1 T-cells: Development, specificity, and function. Annu. Rev. Immunol. 15:535-562. (Pubitemid 27169416)
15. Bengtsson, M., Gordon, J., Flores-Romo, L., Cairns, J. A., Smedmyr, B., Oberg, G., Simonsson, B., and Totterman, T. H. 1989. B-cell reconstitution after autologous bone marrow transplantation: Increase in serum CD23 ("IgE-binding factor") precedes IgE and B-cell regeneration. Blood 73:2139-2144. (Pubitemid 19179546)
16. Bernsen, M. R., de Jongste, C. J., and van der Wouden, C. J. 2003. Lower risk of atopic disorders in whole cell pertussis-vaccinated children. Eur. Respir. J. 22:962-964.
17. Boccafogli, A., Vicentini, L., Lambertini, D., and Scolozzi, R. 1997. Soluble CD23 is increased in allergy. Allergy 52:357-358. (Pubitemid 27166246)
18. Bonnefoy, J. Y., Defrance, T., Peronne, C., Menetrier, C., Rousset, F., Pe, J., de Vries, J. E., and Banchereau, J. 1988. Human recombinant IL-4 induces normal B-cells to produce soluble CD23/IgE-binding factor analogous to that spontaneously released by lymphoblastoid B-cell line. Eur. J. Immunol. 18:117-122. (Pubitemid 18072705)
19. Borres, M. P., Einarsson, R., and Bjkst, B. 1995. Serum levels of IL-4, soluble CD23, and IFNγ in relation to the development of allergic disease during the first 18 months of life. Clin. Exp. Allergy 25:543-548.
20. Bryson, J. K., Wei, X. Q., and Alexander, J. 2008. IL-18 enhances a TH2-biased response and susceptibility to Leishmania mexicana in BALB/c mice. Microbes Infect. 10:834-839.
21. Campbell, A., and Bondy, S. C. 2000. Aluminum-induced oxidative events and its relation to inflammation: A role for the metal in Alzheimer's disease. Cell. Mol. Biol. (Noisy-le-grand) 46:721-730.
22. Cantani A. (Ed.). 2008. Pediatric Allergy, Asthma and Immunology. New York: Springer.
23. Cassel, S. L., Eisenbarth, S. C., Iyer, S. S., Sadler, J. J., Colegio, O. R., Tephly, L. A., Carter, A. B., Rothman, P. B., Flavell, R. A., and Sutterwala, F. S. 2008. The Nalp3 inflammasome is essential for the development of silicosis. Proc. Natl. Acad. Sci. USA 105:9035-9040.
24. Coffin, S., Clark, S., Bos, N., Brubaker, J., and Offit, P. 1999. Migration of antigen-presenting B-cells from peripheral to mucosal lymphoid tissues may induce intestinal antigen-specific IgA following parenteral immunization. J. Immunol. 163:3064-3070. (Pubitemid 29431802)
25. Coffman, R. L., and Carty J. A. 1986. T-Cell activity that enhances polyclonal IgE production and its inhibition by IFNγ. J. Immunol. 136:949-954. (Pubitemid 16146381)
26. Coffman, R. L., Sher, A., and Seder, R. A. 2010. Vaccine adjuvants: Putting innate immuntiy to work. Immunity. 33:492-503.
27. Cruz, C. M., Rinna, A., Forman, H. J., Ventura, A. L., Persechini, P. M., and Ojcius, D. M. 2007. ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of pro-inflammatory cytokines in macrophages. J. Biol. Chem. 282:2871-2879. (Pubitemid 47084344)
28. da Cunha, S. S., Cruz, A. A., Dourado, I., Barreto, M. L., Ferreira, L. D., and Rodrigues, L. C. 2004. Lower prevalence of reported asthma in adolescents with symptoms of rhinitis that received neonatal BCG. Allergy 59:857-862. (Pubitemid 39005827)
29. Dannemann, A., van Ree, R., Kulig, M., Bergmann, R. L., Bauer, P., Forster, J., Guggenmoos-Holzmann, I., Aalberse, R. C., and Wahn, U. 1996. Specific IgE and IgG4 immune responses to tetanus and diphtheria toxiod in atopic and non-atopic children during the first two years of life. Int. Arch. Allergy Immunol. 111:262-267. (Pubitemid 26345384)
30. Delespesse, G., Sarfati, M., and Peleman, R. 1989. Influence of recombinant IL-4, IFNα, and IFNγ on the production of human IgE-binding factor (soluble CD23). J Immunol. 142:134-138. (Pubitemid 19034732)
31. Delespesse, G., Sarfati, M., Wu, C. Y., Fournier, S., and Letellier, M. 1992. The low-affinity receptor for IgE. Immunol. Rev. 125:77-97.
32. Delespesse, G., Suter, U., Mossalayi, D., Bettler, B., Sarfati, M., Hofstetter, H., Kilchherr, E., Debre, P., and Dalloul, A. 1991. Expression, structure and function of the CD23 antigen. Adv. Immunol. 49:149-191.
33. Del Prete, G., Maggi, E., Parronchi, P., Chrien, I., Tiri, A., Macchia, D., Ricci, M., Banchereau, J., de Vries, J., and Romagnani, S. 1988. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T-cell clones and their supernatants. J Immunol. 140:4193-4198.
34. Di Lorenzo, G., Mansueto, P., Melluso, M., Morici, G., Cigna, D., Candore, G., and Caruso, C. 1996. Serum levels of total IgE and soluble CD23 in bronchial asthma. Mediators Inflamm. 5:43-46. (Pubitemid 26109929)
35. Dittrich, A. M., Chen, H. C., Xu, L., Ranney, P., Connolly, S., Yarovinsky, T. O., and Bottomly, H. K. 2008. A new mechanism for inhalation priming: IL-4 by-passes innate immune signals. J. Immunol. 181:7307-7315.
36. Dostert, C., Prilli, V., van Bruggen, R., Steele, C., Mossman, B. T., and Tschopp, J. 2008. Innate immune activation through NALP3 inflammasome sensing of asbestos and silica. Science 320:674-677. (Pubitemid 351928351)
37. Eichenfield, L. F., Hanifin, J. M., Beck, L. A., Lemanske, R. F. Jr., Sampson, H. A., Weiss, S. T., and Leung, D. Y. 2003. Atopic dermatitis and asthma: Parallels in the evolution of treatment. Pediatrics 111:608-616. (Pubitemid 36330720)
38. Eisenbarth, S., Colegio, O., O'Connor, W., Sutterwala, F., and Flavell, R. 2008. Crucial role for the NALP3 inflammasome in the immunostimulatory properties of aluminum adjuvants. Nature 453:1122-1126. (Pubitemid 351871731)
39. El-Demerdash, F. M. 2004. Antioxidant effect of Vitamin E and selenium on lipid peroxidation, enzyme activities, and biochemical parameters in rats exposed to aluminum. J. Trace Elem. Med. Biol. 18:113-121. (Pubitemid 39285971)
40. El-Mezzein, R. E., Matsumoto, T., Nomiyama, H., and Miike, T. 2001. Increased secretion of IL-18 in vitro by peripheral blood mononuclear cells of patients with bronchial asthma and atopic dermatitis. Clin. Exp. Immunol. 126:193-198. (Pubitemid 32995131)
41. Fahy, J. V. 2000. Reducing IgE levels as a strategy for the treatment of asthma. Clin. Exp. Allergy. 30:16-21. (Pubitemid 30341372)
42. Farid, R., Sedaghnia, R., Pishnamaz, R., Masood, A., and Farid, F. 2001. Serum levels of total IgE and IgE binding factor (Soluble CD23) in atopic disorders. Med. J. Iran Hosp. 4:22-24.
43. Franchi, L., and Nez, G. 2008. The Nlrp3 inflammasome is critical for aluminum hydroxide-mediated IL-1β secretion but dispensable for adjuvant activity. Eur. J. Immunol. 38:2085-2089.
44. Global Advisory Committee on Vaccine Safety (GACVS); WHO secretariat. 2009. Global safety of vaccines: Strengthening systems for monitoring, management and the role of GACVS. Expert Rev. Vaccines 8:705-716.
45. Gruber, C., Illi, S., Lau, S., Nickel, R., Forster, J., Kamin, W., Bauer, C. P., Wahn, V., Wahn, U., (MAS-90 Study Group). 2003. Transient suppression of atopy in early childhood is associated with high vaccination coverage. Pediatrics. 111:E282-E288.
46. Gruber, C., Kulig, M., Bergmann, R., Guggenmoos-Holzmann, I., Wahn, U., and the MAS-90 Study Group. 2001. Delayed hypersensitivity to tuberculin, total immunoglobulin E, specific sensitization, and atopic manifestation in longitudinally followed early bacille Calmette-Guerin-vaccinated and non-vaccinated children. Pediatrics 107:E36.
47. Grun, J. L., and Maurer, P. H. 1989. Different T-helper cell subsets elicited in mice utilizing two different adjuvant vehicles: The role of endogenous IL-1 in proliferative responses. Cell. Immunol. 121:134-145. (Pubitemid 19160191)
48. Gudbjartsson, D. F., Bjornsdottir, U. S., Halapi, E., Helgadottir, A., Sulem, P., Jonsdottir, G. M., Thorleifsson, G., Helgadottir, H., Steinthorsdottir, V., Stefansson, H., Williams, C., Hui, J., Beilby, J., Warrington, N. M., James, A., Palmer, L. J., Koppelman, G. H., Heinzmann, A., Krueger, M., Boezen, H. M., Wheatley, A., Altmuller, J., Shin, H. D., Uh, S. T., Cheong, H. S., Jonsdottir, B., Gislason, D., Park, C. S., Rasmussen, L. M., Porsbjerg, C., Hansen, J. W., Backer, V., Werge, T., Janson, C., Jsson, U. B., Ng, M. C., Chan, J., So, W. Y., Ma, R., Shah, S. H., Granger, C. B., Quyyumi, A. A., Levey, A. I., Vaccarino, V., Reilly, M. P., Rader, D. J., Williams, M. J., van Rij, A. M., Jones, G. T., Trabetti, E., Malerba, G., Pignatti, P. F., Boner, A., Pescollderungg, L., Girelli, D., Olivieri, O., Martinelli, N., Ludviksson, B. R., Ludviksdottir, D., Eyjolfsson, G. I., Arnar, D., Thorgeirsson, G., Deichmann, K., Thompson, P. J., Wjst, M., Hall, I. P., Postma, D. S., Gislason, T., Gulcher, J., Kong, A., Jonsdottir, I., Thorsteinsdottir, U., and Stefansson, K. 2009. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat. Genet. 41:342-347.
49. He, J. Q., Chan-Yeung, M., Becker, A. B., Dimich-Ward, H., Ferguson, A. C., Manfreda, J., Watson, W. T., and Sandford, A. J. 2003. Genetic variants of the IL-13 and IL-4 genes and atopic diseases in at-risk children. Genes Immun. 4:385-389. (Pubitemid 38961147)
50. Henderson, J., North, K., Griffiths, M., Harvey, I., and Golding, J. 1999. Pertussis vaccination and wheezing illnesses in young children: Prospective cohort study. The Longitudinal Study of Pregnancy and Childhood Team. Br. Med. J. 318:1173-1176. (Pubitemid 29201570)
51. Hirashima, M., Yodoi, J., and Ishizaka, K. 1980. Regualtory role of IgE-binding factors from rat T-lymphocytes. V. Formation of IgE-potentiating factor by T-lymphocytes from rats treated with Bordetella pertussis vaccine. J. Immunol. 126:838-842.
52. Hirashima, M., Yodoi, J., Ishizaka, K. 1981. Formation of IgE-binding factors by rat T lymphocytes II. Mechanisms of selective formation of IgE-potentiating factors by treatment with Bordetella pertussis vaccine. J. Immunol. 126:838-842. (Pubitemid 11136874)
53. Holmgren, A., and Lu, J. 2010. Thioredoxin and thioredoxin reductase: Current research with special reference to human disease. Biochem. Biophys. Res. Commun. 396:120-124.
54. Holt, P. G., Clough, J. B., Holt, B. J., Baron-Hay, M. J., Rose, A. H., Robinson, B. W., and Thomas, W. R. 1992. Genetic "risk" for atopy is associated with delayed postnatal maturation of T-cell competence. Clin. Exp. Allergy. 22:1093-1099. (Pubitemid 23011171)
55. Holt, P. G., Rudin, A., Macaubas, C., Holt, B. J., Rowe, J., Loh, R., and Sly, P. D. 2000. Development of immunologic memory against tetanus toxiod and pertactin antigens from the diphtheria-tetanuspertussis vaccine in atopic versus non-atopic children. J. Allergy Clin. Immunol. 105:1117-1122.
56. Hong, S. M., Lim, H. W., Kim, I. H., Kim, K., Park, E. H., and Lim, C. J. 2004. Stress-dependent regulation of the gene encoding thioredoxin reductase from the fission yeast. FEMS Microbiol. Lett. 234:379-385. (Pubitemid 38595656)
57. Hurwitz, L. E., and Morgenstern, H. 2000. Effects of diphtheria- tetanuspertussis or tetanus vaccination on allergies and allergy-related respiratory symptoms among children and adolescents in the United States. J. Manipulative Physiol. 23:81-90.
58. Imboden, M., Nicod, L., Nieters, A., Glaus, E., Matyas, G., Bircher, A. J., Ackermann-Liebrich, U., Berger, W., Probst-Hensch, N. M., and the SAPALDIA Team. 2005. The common G-allele of IL-18 singlenucleotide polymorphism is a genetic risk factor for atopic asthma. The SAPALDIA Cohort Study. Clin. Exp. Allergy 36:211-218.
59. Ippolito, J. A., Scheckel, K. G., and Barbarick, K. A. 2009. Selenium adsorption to aluminum-based water treatment residuals. J. Colloid Interface Sci. 338:48-55.
60. Jankovic, D., Caspar, P., Zweig, M., Garcia-Moll, M., Showalter, S. D., Vogel, F. R., and Sher, A. 2008. Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as Type 1 cytokine responses to HIV-1 gp120. J. Immunol. 159:2409-2417.
61. Jedrychowski, W., Maugeri, U., and Jedrychowska-Bianchi, I. 2004. Prospective epidemiologic study on respiratory diseases in children and immunization against measles. Int. J. Occup. Med. Environ. Health. 17:255-261. (Pubitemid 38915555)
62. Jin, C., and Flavell, R. A. 2010. Inflammasome activation. The missing link: How the inflammasome senses oxidative stress. Immunol. Cell. Biol. 88:510-512.
63. Jung, H. I., Lim, H. W., Kim, B. C., Park, E. H., and Lim, C. J. 2004. Differential thioredoxin reductase activity from human normal hepatic and hepatoma cell lines. Yonsei Med. J. 45:263-272.
64. Kabesch, M., Schedel, M., Carr, D., Woitsch, B., Fritzsch, C., Weiland, S. K., and von Mutius, E. 2006. IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. J. Allergy Clin. Immunol. 117:269-274. (Pubitemid 43190139)
65. Kabesch, M., Tzotcheva, I., Carr, D., Hofler, C., Weiland, S. K., Fritzsch, C., von Mutius, E., and Martinez, F. D. 2003. A complete screening of the IL-4 gene: Novel ploymorphisms and their association with asthma and IgE in childhood. J. Allergy Clin. Immunol. 112:893-898. (Pubitemid 37412056)
66. Kalaboka, S., and Annesi-Maesano, I. 2007. The complex link between immunization against childhood diseases and allergy. Expert Rev. Vaccines 6:65-643.
67. Kelso, J. M. 2009. Update on vaccination guidelines for allergic children. Expert Rev. Vaccines 8:1541-1546.
68. Kemp, T., Pearce, N., Fitzharris, P., Crane, J., Fergusson, D., St. George, I., Wickens, K., and Beasley, R. 1997. Is infant immunization a risk factor for childhood asthma or allergy Epidemiology 8:678-680. (Pubitemid 27449501)
69. Kim, K. M., Mayumi, M., and Mikawa, H. 1992. IgE, IL-4, and soluble FcγRII in the serum of atopic and non-atopic children. Pediatr. Allergy Immunol. 3:11-15.
70. Kim, K. M., Nanbu, M., Iwai, Y., Tanaka, M., Yodoi, J., Mayumi, M., and Mikawa, H. 1989. Soluble low affinity Fc receptors for IgE in the serum of allergic and non-allergic children. Pediatr. Res. 26:49-53.
71. Kisaki, T., Leung, Y. M. D., Jardieu, P., Geha, S. R., and Ishizaka, K. 1988. Regulatory effects of human IgE-binding factors in the IgE synthesis by human and rat lymphocytes. Eur. J. Immunol. 18:1663-1670. (Pubitemid 19011571)
72. Kondo, Y., Yoshimoto, T., Yasuda, K., Futatsugi-Yumikura, S., Morimoto, M., Hayashi, N., Hoshino, T., Fujimoto, J., and Nakanishi, K. 2008. Administration of IL-33 induces airway hyper-responsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int. Immunol. 20:791-800. (Pubitemid 351791523)
73. Konishi, H., Tsutsui, H., Murakami, T., Yumikura-Futatsugi, S., Yamanaka, K., Tanaka, M., Iwakura, Y., Suzuki, N., Takeda, K., Akira, S., Nakanishi, K., and Mizutani, H. 2002. IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/STAT6 under specific pathogen-free conditions. Proc. Natl. Acad. Sci. USA 99:11340-11345. (Pubitemid 34920927)
74. Kool, M., Petrilli, V., De Smedt, T., Rolaz, A., Hammad, H., van Nimwegen, M., Bergen, I. M., Castillo, R., Lambrecht, B. N., and Tschopp, J. 2008. Cutting Edge: Alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J. Immunol. 181:3755-3759.
75. Koppen, S., Groot, D. R., Neijens, H. J., Nagelkerke, N., van Eden, W., and Rumke, H. C. 2004. No epidemiological evidence for infant vaccinations to cause allergic disease. Vaccine 22:3375-3385. (Pubitemid 39078755)
76. Kruse, S., Kuehr, J., Moseler, M., Kopp, M. V., Kurz, T., Deichmann, K. A., Foster, P. S., and Mattes, J. 2003. Polymorphisms in the IL-18 gene are associated with specific sensitization to common allergens and allergic rhinitis. Allergy Clin. Immunol. 111:117-122. (Pubitemid 36143301)
77. Kumar, V., Bal, A., and Gill, K. D. 2008. Impairment of mitochondrial energy metabolism in different regions of rat brain following chronic exposure to aluminum. Brain Res. 1232:94-103.
78. Kuroda, E., Ishii, K., Uematsu, S., Ohata, K., Coban, C., Akira, S., Aritake, K., Urade, Y., and Morimoto, Y. 2011. Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms. Immunity 34:514-526.
79. Lebman, D., and Coffman, R. 1998. IL-4 causes isotype switching to IgE in T-cell-stimulated clonal B-cell cultures. J. Exp. Med. 168:853-862.
80. Leung, D., Young, M., Wood, N., and Geha, R. 1986. Induction of IgE synthesis in normal human B-cells. Sequential requirements for activation by an alloreactive T-cell clone and IgE-potentiating factors. J. Exp. Med. 163:713-723. (Pubitemid 16141972)
81. Li, H., Nookala, S., and Re, F. 2007. Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1β and IL-18 release. J. Immunol. 178:5271-5276. (Pubitemid 46595312)
82. Li, H., Willingham, S. B., Ting, J. P., and Re, F. 2008. Cutting Edge: Inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J. Immunol. 181:17-21.
83. Lopez, A. F., Shannon, M. F., Chia, M. M., Park, L., and Vadas, M. A. 1992. Regulation of human eosinophil production and function by IL-5. Immunol. Ser. 57:549-571.
84. Lundgren, M., Persson, U., Larsson, P., Magnusson, C., Smith, C. E., Hammarstrom, L., and Severinson, E. 1989. Interleukin-4 induces synthesis of IgE and IgG4 in human B-cells. Eur. J. Immunol. 19:1311-1315. (Pubitemid 19196912)
85. Mahon, B. P., Ryan, M. S., Griffin, F., and Mills K. H. 1996. Interleukin-12 produced by macrophages in response to live or killed Bordetella pertussis enhances the efficacy of an acellular pertussis vaccine by promoting induction of TH1 cells. Infect. Immun. 64:5295-5301. (Pubitemid 26403995)
86. Maitra, A., Sherriff, A., Griffiths, M., and Henderson, J.; (Avon Longitudinal Study of Parents and Children Study Team). 2004. Pertussis vaccination in infancy and asthma or allergy in later childhood: Birth cohort study. Br. Med. J. 328:925-926. (Pubitemid 38496983)
87. Marks, B. G., Ng, K., Zhou, J., Toelle, B. G., Xuan, W., Belousova, E. G., and Britton, W. J. 2003. The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: An historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease. J. Allergy Clin. Immunol. 111:541-549. (Pubitemid 36337875)
88. Marsh, D. G., Neely, J., Breazeale, D. R., Ghosh, B., Freidhoff, L. R., Ehrlich-Kautzky, E., Schou, C., Krishnaswamy, G., and Beaty, T. H. 1994. Linkage analysis of IL-4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 264:1152-1156. (Pubitemid 24210678)
89. McKee, A. S., Munks, M. W., MacLeod, M. K., Fleenor, C. J., van Rooijen, N., Kappler, J. W., and Marrack, P. 2009. Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity. J. Immunol. 183:4403-4414.
90. McKeever, M. T., Lewis, A. S., Smith, C., and Hubbard, R. 2004. Vaccination and allergic disease: A birth cohort study. Am. J. Public Health. 94:985-989. (Pubitemid 38691544)
91. Mohrenschlager, M., Haberi, M. V., Kramer, U., Behredt, H., and Ring, J. 2007. Early BCG and pertussis vaccination and atopic diseases in 5-to 7-year-old preschool children from Augsburg, Germany: Results from the MIRIAM study. Pediatr. Allergy Immunol. 18:5-9. (Pubitemid 46232277)
92. Mota, I. 1964. The mechanism of anaphylaxis. I. Production, and biological properties of mast cell sensitizing antibody. Immunology 7:681-699.
93. Murakami, K., and Yoshino, M. 2004. Aluminum decreases the glutathione regeneration by the inhibition of NADP-isocitrate dehydrogenase in mitochondria. J. Cell. Biochem. 93:1267-1271. (Pubitemid 44264138)
94. Murphy, G. E., Xu, D., Liew, F. Y., and McInnes, I. B. 2010. Role of IL-33 in human immunopathology. Ann. Rheum. Dis. 69:i43-i47.
95. Nagel, J. E., White, C., Lin, M. S., and Fireman, P. 1978. IgE synthesis in man: II. Comparison of tetanus and diphtheria IgE antibody in allergic and nonallergic children. J. Allergy Clin. Immunol. 5:308-314. (Pubitemid 10218811)
96. Nakanishi, K., Yoshimoto, T., Tsutsui, H., and Okamura, H. 2001. IL-18 is a unique cytokine that stimulates both TH1 and TH2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev. 12:53-72. (Pubitemid 32294587)
97. Newport, M. J., Goetghebuer, T., and Weiss, H. A. 2004. Genetic regulation of immune responses to vaccines in early life. Genes Immunity 5:122-129. (Pubitemid 38967641)
98. Nilsson, L., Kjellman, I. N., and Bjorkstem, B. 2003. Allergic disease at the age of 7 years after pertussis vaccination in infancy: Results from the follow-up of a randomized controlled trial of 3 vaccines. Arch. Pediatr. Adolsec. 157:1184-1189. (Pubitemid 37521225)
99. Novak, N., Kruse, S., Potreck, J., Maintz, L., Jenneck, C., Weidinger, S., Fimmers, R., and Bieber, T. 2005. Single nucleotide polymorphisms of the IL-18 gene are associated with atopic eczema. J. Allergy Clin. Immunol. 115:828-833. (Pubitemid 40460861)
100. Nutman, T., Volkman, D., Hussain, R., Fauci, A., and Ottesen, E. 1985. Filarial parasite-specific T-cell lines: Induction of IgE synthesis. J. Immunol. 134:1178-1184. (Pubitemid 15158612)
101. Odelram, H., Granstrom, M., Hedenskog, S., Duchen, K., and Bjorksten, B. 1994. Immunoglobulin E and G responses to pertussis toxin after booster immunization in relation to atopy, local reactions, and aluminum content of the vaccines. Pediatr. Allergy Immunol. 5:118-123. (Pubitemid 24215643)
102. Olesen, B. A., Juul, S., and Thestrup-Pedersen, K. 2003. Atopic dermatitis is increased following vaccination for measles, mumps, and rubella or measles infection. Acta Derm. 83:445-450. (Pubitemid 37475787)
103. Pace, L., Rizzo, C., Palombi, C., Brombacher, F., and Doria, G. 2006. Cutting Edge: IL-4-induced protection of CD4+CD25-TH cells from CD4+CD25+ regulatory T-cell-mediated suppression. J. Immunol. 176:3900-3904. (Pubitemid 44264365)
104. Parronchi, P., Tiri, A., Macchia, D., De Carli, M., Biswas, P., Simonelli, C., Maggi, E., Del Prete, G., Ricci, M., and Romagnani, S. 1990. Non-cognate contact-dependent B-cell activation can promote IL-4-dependent in vitro human IgE synthesis. J. Immunol. 144:2102-2108. (Pubitemid 20106546)
105. Pauwels, R., van der Straeten, M., Platteau, B., and Bazin, H. 1983. The non-specific enhancement of allergy. Allergy 38:239-246.
106. Pe, J., Rivier, A., Lagier, B., Becker, W. M., Michel, F.-B., Bousquet, J. 1994. Differences in IL-4 release by PBMC are related with heterogeneity of atopy. Immunology 81:58-64. (Pubitemid 24249833)
107. Pe J., Rousset, F., Brie, F., Chrien, I., Bonnefoy, J. Y., Spits, H., Yokota, T., Arai, N., Arai, K., Banchereau, J., and de Vries, J 1988,IgE production by normal human lymphocytes is induced by IL-4 and suppressed by interferons-γ and-α and prostaglandin E2. Immunology 85, 6880-6884.
108. Pollock, K., Conacher, M., Wei, X. Q., and Brewer, A. J. 2003. Interleukin-18 plays a role in both the alum-induced TH2 response and the T-helper-1 response induced by alum-adsorbed interleukin-12. Immunology 108:137-143. (Pubitemid 36232862)
109. Punnonen, J., Aversa, G., Cocks, B. G., McKenzie, A. N., Menon, S., Zurawski, G., de Waal Malefyt, R., and de Vries, J. E. 1993. IL-13 induces IL-4-independent IgG4 and IgE synthesis and CD23 expression by human B-cells. Proc. Natl. Acad. Sci. USA 90:3730-3734. (Pubitemid 23111441)
110. Puren, A. J., Fantuzzi, G., and Dinarello, C. A. 1999. Gene expression, synthesis, and secretion of IL-18 and IL-1β are differentially regulated in human blood mononuclear cells and mouse spleen cells. Proc. Natl. Acad. Sci. USA 96:2256-2261. (Pubitemid 29117901)
111. Puren, A. J., Fantuzzi, G., Gu, Y., Su, M. S., and Dinarello, C. A. 1998. Interleukin-18 (IFNγ-inducing factor) induces IL-8 and IL-1β via TNFα production from non-CD14+ human blood mononuclear cells. J. Clin. Invest. 101:711-721. (Pubitemid 28084257)
112. Rank, M., Kobayashi, T., Kozaki, H., Bartemes, K. R., Squillace, D. L., and Kita, H. 2009. IL-33-activated dendritic cells induce an atypical TH2-type response. J. Allergy Clin. Immunol. 123:1047-1054.
113. Rincon, M., Anguita, J., Nakamura, T., Fikrig, E., and Flavell, R. A. 1997. IL-6 directs the differentiation of IL-4-producing CD4+ T-cells. J. Exp. Med. 185:461-469. (Pubitemid 27078364)
114. Robinson, D. S., Hamid, Q., Ying, S., Tsicopoulos, A., Barkans, J., Bentley, A. M., Corrigan, C., Durham, S. R., and Kay, A. B. 1992. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298-304.
115. Rosenwasser, L. J., Klemm, D. J., Dresback, J. K., Inamura, H., Mascali, J. J., Klinnert, M., and Borish, L. 1995. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin. Exp. Allergy 25:74-78.
116. Rowe, J., Macaubas, C., Monger, T., Holt, B. J., Harvey, J., Poolman, J. T., Loh, R., Sly, P. D., and Holt, P. G. 2001. Heterogeneity in diphtheria-tetanus-acellular pertussis vaccine-specific cellular immunity during infancy: Relationship to variations in the kinetics of postnatal maturation of systemic TH1 function. J. Infect. Dis. 184:80-88. (Pubitemid 32568504)
117. Sakashita, M., Yoshimoto, T., Hirota, T., Harada, M., Okubo, K., Osawa, Y., Fujieda, S., Nakamura, Y., Yasuda, K., Nakanishi, K., and Tamari, M. 2008. Association of serum IL-33 level and the IL-33 genetic variant with Japanese cedar pollinosis. Clin. Exp. Allergy 38:1875-1881.
118. Schatz, D. A., and Barrett, D. J. 1987. Evolution of the subclass of IgG antibody to Type 3 pneumococcal polysaccharide during childhood. Clin. Exp. Immunol. 70:449-455. (Pubitemid 17164908)
119. Schedel, M., Carr, D., Klopp, N., Woitsch, B., Illig, T., Stachel, D., Schmid, I., Fritzsch, C., Weiland, S. K., von Mutius, E., and Kabesch, M. 2004. A signal transducer and activator of transcription 6 haplotype influence the regulation of serum IgE levels. J. Allergy Clin. Immunol. 114:1100-1105. (Pubitemid 39469150)
120. Schipf, A., Heilmann, A., Boue, L., Mossmann, H., Brocker, T., Rocken, M. 2003. TH2 cells shape the differentiation of developing T-cell responses during interactions with dendritic cells in vivo. Eur. J. Immunol. 33:1697-1706. (Pubitemid 36790431)
121. Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., Gorman, D. M., Bazan, J. F., and Kastelein, R. A. 2005. IL-33, an IL-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T-helper type-2-associated cytokines. Immunity 23:479-490. (Pubitemid 41587888)
122. Schroder, K., Zhou, R., and Tschopp, J. 2010. The NLRP3 inflammasome: A sensor for metabolic danger Science 327:296-300.
123. Shang, X. Z., Armstrong, J., Yang, G. Y., Volk, A., Li, J., Griswold, D. E., Emmell, E., and Li, L. 2004. Regulation of antigen-specific versus by-stander IgE production after antigen sensitization. Cell. Immunol. 229:106-116. (Pubitemid 39330218)
124. Sharp, F. A., Ruane, D., Claass, B., Creagh, E., Harris, J., Malyala, P., Singh, M., O'Hagan, D. T., Prilli, V., Tschopp, J., O'Neill, L. A., and Lavelle, E. C. 2009. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc. Natl. Acad. Sci. USA 106:870-875.
125. Smith, D. E. 2011. The biological paths of IL-1 family members IL-18 and IL-33. J. Leukocyte Biol. 89:383-392.
126. Smithgall, M. D., Comeau, M. R., Yoon, B. R., Kaufman, D., Armitage, R., and Smith, D. E. 2008. IL-33 amplifies both TH1-and TH2-type responses through its activity on human basophils, allergenreactive TH2 cells, iNKT, and NK Cells. Int. Immunol. 20:1019-1030.
127. Snapper, C. M., Finkelman, F. D., and Paul, W. E. 1988. Regulation of IgG1 and IgE production by interleukin 4. Immuno. Rev. 102:51-75. (Pubitemid 18095720)
128. Sokolovska, A., Hem, S., and Hogen Esch, H. 2007. Activation of dendritic cells and induction of CD4+ T-cell differentiation by aluminum-containing adjuvants. Vaccine 25:4575-4585. (Pubitemid 46734537)
129. Suemura, M., Yodoi, J., Hirashima, M., and Ishizaka, K. 1980. Regulatory role of IgE-binding factors from rat T-lymphocytes. I. Mechanisms of enhancement of IgE response by IgE-potentiating factor. J. Immunol. 125:148-154. (Pubitemid 10040413)
130. Uede, T., Huff, T. F., and Ishizaka, K. 1982. Formation of IgE-binding factors by rat T-lymphocytes. V. Effect of adjuvant for the priming immunization on the nature of IgE bnding factors formed by antigenic stimulation. J. Immunol. 129:1384-1390. (Pubitemid 12031058)
131. Ulanova, M., Tarkowski, A., Hahn-Zoric, M., and Hanson, L. A. 2000. The common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an IL-4-dependent mechanism. Infect. Immun. 69:1151-1159. (Pubitemid 32109584)
132. Umetsu, D. T., Leung, D. Y., Siraganian, R., Jabara, H. H., and Geha, R. S. 1985. Differential requirements of B-cells from normal and allergic subjects for the induction of IgE synthesis by an alloreactive T-cell clone. J. Exp. Med. 162:202-214. (Pubitemid 15029897)
133. Van der Velden, V. H., Laan, M. P., Baert, M. R., de Wael, M. R., Neijens, H. J., and Savelkoul, H. F. 2001. Selective development of a strong TH2 cytokine profile in high-risk children who develop atopy: Risk factors and regulatory role of IFNγ, IL-4, and IL-10. Clin. Exp. Allergy 31:997-1006. (Pubitemid 32862828)
134. Verhaeqhe, B., Gevaert, P., Holtappels, G., Lukat, K. F., Lange, B., van Cauwenberge, P., and Bachert, C. 2002. Up-regulation of IL-18 in allergic rhinitis. Allergy 57:825-830. (Pubitemid 34970007)
135. Victoratos, P., Yiangou, M., Avramidis, N., and Hadjipetrou, L. 1997. Regulation of cytokine gene expression by adjuvants in vivo. Clin. Exp. Immunol. 109:569-578. (Pubitemid 27402329)
136. Wei, X. Q., Niedbala, W., Xu, D., Luo, Z. X., Pollock, K., and Brewer, J. 2004. Host genetic background determines whether IL-18 deficiency results in increased susceptibility or resistance to murine Leishmania major infection. Immunol. Lett. 94:35-37. (Pubitemid 38953709)
137. Weidinger, S., Klopp, N., Wagenpfeil, S., Rummler, L., Schedel, M., Kabesch, M., Schafer, T., Darsow, U., Jakob, T., Behrendt, H., Wichmann, H., Ring, J., and Illig, T. 2004. Association of a STAT 6 haplotype with elevated serum IgE levels in a population based cohort of white adults. J. Med. Genet. 41:658-663. (Pubitemid 39208605)
138. Wen, H., Dou, Y., Hogaboam, C. M., and Kunkel, S. L. 2008a. Epigenetic regulation of dendritic cell-derived IL-12 facilitates immunosuppression after a severe innate immune response. Blood 111:1797-1804. (Pubitemid 351451484)
139. Wen, H., Hogaboam, C. M., Gauldie, J., and Kunkel, S. L. 2006. Severe sepsis exacerbates cell-mediated immunity in the lung due to an altered dendritic cell cytokine profile. Am. J. Pathol. 168:1940-1950. (Pubitemid 43825314)
140. Wen, H., Schaller, M. A., Dou, Y., Hogaboam, C. M., and Kunkel, S. L. 2008b. Dendritic cells at the interface of innate and acquired immunity: The role for epigenetic changes. J. Leukocyte Biol. 83:439-446. (Pubitemid 351966848)
141. Wheeler, D. J., Parveen, S., Pollock, K., and Williams, R. J. 1998. Inhibition of sCD23 and IgE release from human B-cells by a metalloproteinase inhibitor, GI 129471. Immunology 95:105-110. (Pubitemid 28410507)
142. Wheeler, A. W., Marshal, J. S., and Ulrich, J. T. 2001. A TH1-inducing adjuvant, MPL, enhances antibody profiles in experimental animals suggesting it has the potential to improve the efficacy of allergy vaccines. Int. Arch. Allergy Immunol. 126:135-139. (Pubitemid 33135391)
143. Wiertsema, S. P., Baynam, G., Khoo, S. K., Veenhoven, R. H., van Heerbeek, N., Zhang, G., Laing, I. A., Rijkers, G. T., Goldblatt, J., Sanders, E. A., and Le Sou, P. N. 2007. Impact of genetic variants in IL-4, IL-4 RA, and IL-13 on the anti-pneumococcal antibody response. Vaccine 25:306-313. (Pubitemid 44856074)
144. Wilhelm, D., Klouche, M., Gg, S., and Kirchner, H. 1994. Expression of sCD23 in atopic and non-atopic blood donors: Correlation with age, total serum IgE, and allergic symptoms. Allergy 49:521-525. (Pubitemid 24287291)
145. Yamanishi, R., Yusa, I., Bando, N., and Terao, J. 2003. Adjuvant activity of alum in inducing antigen specific IgE antibodies in BALB/c mice: A re-evaluation. Biosci. Biotechnol. Biochem. 67:166-169. (Pubitemid 39260160)
146. Yan, Z., Garg, S. K., and Banerjee, R. 2010. Regulatory T-cells interfere with glutathione metabolism in dendritic cells and T-cells. J. Biol. Chem. 285:41525-41532.
147. Yan, Z., Garg, S. K., Kipnis, J., and Banerjee, R. 2009. Extracellular redox modulation by regulatory T-cells. Nat. Chem. Biol. 5:721-723.
148. Yanagawa, Y., Suzuki, M., Matsumoto, M., and Togashi, H. 2011. Prostaglandin E2 enhances IL-33 production by dendritic cells. Immunol. Lett. 141:55-60.
149. Yanagihara, Y., Sarfati, M., Marsh, D., Nutman, T., and Delespesse, G. 1990. Serum levels of IgE-binding factor (soluble CD23) in diseases associated with elevated IgE. Clin. Exp. Allergy 20:395-401. (Pubitemid 20208477)
150. Yilmaz, M., Bingol, G., Altinta, D., and Kendirli, S. G. 2000. Correlation between atopic diseases and tuberculin responses. Allergy 55:664-667. (Pubitemid 30439001)
151. Yodoi, J., Hirashima, M., and Ishizaka, K. 1980. Regulatory role of IgEbinding factors from rat T-lymphocytes. II. Glycoprotein nature and source of IgE-potentiating factor. J. Immunol. 125:1436-1441. (Pubitemid 10018542)
152. Yoshimoto, T., Min, B., Sugimoto, T., Hayashi, N., Ishikawa, Y., Sasaki, Y., Hata, H., Takeda, K., Okumura, K., van Kaer, L., Paul, W. E., and Nakanishi, K. 2003. Non-redundant roles for CD1d-restricted natural killer T-cells and conventional CD4+ T-cells in the induction of immunoglobulin E antibodies in response to IL-18 treatment of mice. J. Exp. Med. 197:997-1005. (Pubitemid 36523197)
153. Yoshimoto, T., Mizutani, H., Tsutsui, H., Noben-Trauth, N., Yamanaka, K., Tanaka, M., Izumi, S., Okamura, H., Paul, W. E., and Nakanishi, K. 2000. IL-18 induction of IgE: Dependence on CD4+ T-cells, IL-4 and STAT6. Nat. Immunol. 1:132-137.
154. Yoshimoto, T., Tsutsui, H., Tominaga, K., Hoshino, K., Okamura, H., Akira, S., Paul, W. E., and Nakanishi, K. 1999. IL-18, although anti-allergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. Proc. Natl. Acad. Sci. USA 96:13962-13966.
155. Yoshimoto, T., and Paul, W. E. 1994. CD4+, NK1.1+ T-cells promptly produce IL-4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179:1285-1295.
156. Yoshizawa, Y., Nomaquchi, H., Izaki, S., and Kitamura, K. 2002. Serum cytokine levels in atopic dermatitis. Clin. Exp. Dermatol. 27:225-229. (Pubitemid 34639288)
157. Young, M., Leung, D., and Geha, R. 1984. Production of IgE-potentiating factor in man by T-cell lines bearing Fc receptors for IgE. Eur. J. Immunol. 14:871-878. (Pubitemid 14020566)
158. Zagrodzki, P., Barto, H., Walas, S., Fołta, M., Stomp, T., Janusz-Grzybowska, E., Drozdz, M., and Sułowicz, W. 2007. Selenium status indices, laboratory data, and selected biochemical parameters in end-stage renal disease patients. Biol. Trace Elem. Res. 116:29-41. (Pubitemid 47186533)
159. Zhou, R., Tardivel, A., Thorens, B., Choi, I., and Tschopp, J. 2010. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11:136-140.